$CBDY
Target Group Inc.

2015 Q4 Form 10-K Financial Statement

#000114420416089606 Filed on March 22, 2016

View on sec.gov

Income Statement

Concept 2015 Q4 2015 2014 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $100.0K $428.2K $120.0K
YoY Change -16.67% 78.72%
% of Gross Profit
Research & Development $180.0K $31.32K $50.00K
YoY Change 260.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.320M $2.747M $170.0K
YoY Change 1264.71% 666.8%
Operating Profit
YoY Change
Interest Expense $0.00 $1.543K $0.00
YoY Change 1060.15%
% of Operating Profit
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$2.320M -$2.748M -$240.0K
YoY Change 866.67% 666.94%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$2.320M -$2.748M -$240.0K
YoY Change 866.67% 666.94%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$232.0M -$341.4M -$24.00M
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q4 2015 2014 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $840.00 $0.00
YoY Change -22.22%
Cash & Equivalents $838.00 $1.084K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $0.00
Receivables $0.00
Other Receivables
Total Short-Term Assets $838.00 $840.00 $1.084K
YoY Change -22.69% -22.22% -45.8%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $838.00 $840.00 $1.084K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $838.00 $840.00 $1.084K
YoY Change -22.69% -22.22% -45.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $400.0K $400.0K $250.0K
YoY Change 60.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $12.50K $12.50K $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.089M $1.089M $279.6K
YoY Change 289.38% 289.38% 69809.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.089M $1.089M $279.6K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $1.089M $1.089M $279.6K
YoY Change 289.38% 289.38% 69809.0%
SHAREHOLDERS EQUITY
Retained Earnings -$3.107M -$359.0K
YoY Change 765.54% 54541.86%
Common Stock $2.019M $80.45K
YoY Change 2410.1% 3464.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.088M -$1.088M -$278.6K
YoY Change
Total Liabilities & Shareholders Equity $838.00 $840.00 $1.084K
YoY Change -22.69% -22.22% -45.8%

Cashflow Statement

Concept 2015 Q4 2015 2014 Q4
OPERATING ACTIVITIES
Net Income -$2.320M -$2.748M -$240.0K
YoY Change 866.67% 666.94%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$60.00K -$192.4K -$10.00K
YoY Change 500.0% 2014.73%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$12.50K
YoY Change 52.66%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 60.00K 192.2K 0.000
YoY Change 2246.76%
NET CHANGE
Cash From Operating Activities -60.00K -192.4K -10.00K
Cash From Investing Activities 0.000 0.000
Cash From Financing Activities 60.00K 192.2K 0.000
Net Change In Cash 0.000 -240.0 -10.00K
YoY Change -100.0% -73.63%
FREE CASH FLOW
Cash From Operating Activities -$60.00K -$192.4K -$10.00K
Capital Expenditures $0.00 $0.00
Free Cash Flow -$60.00K -$192.4K
YoY Change 2014.73%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2017181 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
79755 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
-278552 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1084 USD
CY2014Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
28239 USD
CY2014Q4 us-gaap Liabilities
Liabilities
279636 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-358997 USD
CY2014 us-gaap Interest Expense
InterestExpense
133 USD
CY2015 us-gaap Interest Expense
InterestExpense
1543 USD
CY2015 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2748266 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-2748266 USD
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.34
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
8053274 shares
CY2015 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
284869 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
12000 USD
CY2014 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
0 USD
CY2014 us-gaap Operating Expenses
OperatingExpenses
358207 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
250997 USD
CY2015 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
629522 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-37343 USD
CY2015 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-179943 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
36427 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
179697 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-916 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-246 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2000 USD
CY2014 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
28239 USD
CY2015 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
179697 USD
CY2015 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 USD
CY2014 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
2000 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
10188 USD
CY2015Q3 chzp Common Stock Shares Offered
CommonStockSharesOffered
1500000 shares
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q3 us-gaap Share Price
SharePrice
0.50
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20650000 shares
CY2015Q4 us-gaap Assets Current
AssetsCurrent
838 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
1084 USD
CY2014Q4 us-gaap Assets
Assets
1084 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
690 USD
CY2015Q4 us-gaap Assets
Assets
838 USD
CY2015Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
480919 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
51397 USD
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1088855 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
279636 USD
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
2065 USD
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-1088017 USD
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
838 USD
CY2015Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
195436 USD
CY2015Q4 us-gaap Liabilities
Liabilities
1088855 USD
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3107263 USD
CY2015 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
31323 USD
CY2014 us-gaap Research And Development Expense Software Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseSoftwareExcludingAcquiredInProcessCost
48590 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
9291 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
3000 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
2746723 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
0 USD
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
1211834 USD
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance Noncurrent
DeferredTaxAssetsValuationAllowanceNoncurrent
140009 USD
CY2015Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
0 USD
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
0 USD
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6900000 shares
CY2015 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2013-07-09
CY2015Q4 chzp Working Capital Deficit
WorkingCapitalDeficit
1088017 USD
CY2015 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">USE OF ESTIMATES</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><font style="FONT-SIZE: 10pt">CONCENTRATION OF RISK</font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation limit as of December 31, 2015.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0 USD
CY2014 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
70000 USD
CY2014Q2 chzp Common Stock Redemption Price Per Share
CommonStockRedemptionPricePerShare
0.0001
CY2014Q2 chzp Common Stock Redemption Price Per Share
CommonStockRedemptionPricePerShare
0.0001
CY2014Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
88000 shares
CY2014Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
88 USD
CY2014Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
20000 shares
CY2014Q3 chzp Equity Issuance Per Share
EquityIssuancePerShare
0.50
CY2014Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000 USD
CY2014Q3 chzp Equity Issuance Per Share
EquityIssuancePerShare
0.0001
CY2015 chzp Monthly Lease And Rental Expense
MonthlyLeaseAndRentalExpense
1000 USD
CY2015Q4 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
1211834 USD
CY2014Q4 us-gaap Deferred Tax Assets Gross Noncurrent
DeferredTaxAssetsGrossNoncurrent
140009 USD
CY2015Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3107263 USD
CY2015 chzp Operating Loss Expiration Period Description
OperatingLossExpirationPeriodDescription
2036
CY2015 chzp Term Of Agreement Entered For Advisory Services
TermOfAgreementEnteredForAdvisoryServices
P3M
CY2015Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
336111 USD
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
1600 USD
CY2014 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1950 USD
CY2014 chzp Stock Redeemed Or Called During Period Value For Common Stock
StockRedeemedOrCalledDuringPeriodValueForCommonStock
-50 USD
CY2015 chzp Shares Issued As Consideration For Acquisition Of Intangible Assets
SharesIssuedAsConsiderationForAcquisitionOfIntangibleAssets
0 USD
CY2014 chzp Shares Issued As Consideration For Acquisition Of Intangible Assets
SharesIssuedAsConsiderationForAcquisitionOfIntangibleAssets
70000 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1071823 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-139753 USD
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1071823 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
139753 USD
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.39 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.39 pure
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20650000 shares
CY2016Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2016-09-01
CY2015Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
400000 USD
CY2014Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
200000 USD
CY2015 chzp Proceeds From Issuance Of Common Stock For Management Services
ProceedsFromIssuanceOfCommonStockForManagementServices
100000 USD
CY2014 us-gaap Interest Paid
InterestPaid
0 USD
CY2014 chzp Proceeds From Issuance Of Common Stock For Management Services
ProceedsFromIssuanceOfCommonStockForManagementServices
0 USD
CY2015 chzp Proceeds From Issuance Of Common Stock For Advisory And Other Services
ProceedsFromIssuanceOfCommonStockForAdvisoryAndOtherServices
1838801 USD
CY2014 chzp Proceeds From Issuance Of Common Stock For Advisory And Other Services
ProceedsFromIssuanceOfCommonStockForAdvisoryAndOtherServices
0 USD
CY2015Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
12500 USD
CY2014Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
0 USD
CY2015 us-gaap Interest Paid
InterestPaid
0 USD
CY2015 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2014 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 USD
CY2015 us-gaap Management Fee Expense
ManagementFeeExpense
300000 USD
CY2014 us-gaap Management Fee Expense
ManagementFeeExpense
200000 USD
CY2014 chzp Stock Issued During Period Shares Issued For Cash Value
StockIssuedDuringPeriodSharesIssuedForCashValue
10188 USD
CY2015 us-gaap Professional Fees
ProfessionalFees
2033611 USD
CY2014 us-gaap Professional Fees
ProfessionalFees
0 USD
CY2015 us-gaap Legal Fees
LegalFees
75629 USD
CY2014 us-gaap Legal Fees
LegalFees
36617 USD
CY2014 us-gaap Stock Issued During Period Value Purchase Of Assets
StockIssuedDuringPeriodValuePurchaseOfAssets
70000 USD
CY2015 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
100000 USD
CY2015 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
1838801 USD
CY2015 us-gaap Asset Impairment Charges
AssetImpairmentCharges
70000 USD

Files In Submission

Name View Source Status
0001144204-16-089606-index-headers.html Edgar Link pending
0001144204-16-089606-index.html Edgar Link pending
0001144204-16-089606.txt Edgar Link pending
0001144204-16-089606-xbrl.zip Edgar Link pending
chzp-20151231.xml Edgar Link completed
chzp-20151231.xsd Edgar Link pending
chzp-20151231_cal.xml Edgar Link unprocessable
chzp-20151231_def.xml Edgar Link unprocessable
chzp-20151231_lab.xml Edgar Link unprocessable
chzp-20151231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v434814_10k.htm Edgar Link pending
v434814_ex31-1.htm Edgar Link pending
v434814_ex32-1.htm Edgar Link pending